protein
| receptor for the semaphorin 7A (SEMA7A) |
|
semaphorin 3E (Sema3E), one of the ligands for PLXND1, has previously been correlated with invasive behavior and metastasis, suggesting that the PLXND1-SEMA3E interaction may play a role in tumor progression (Roodink 2008) |
|
receptor of SEMA3E (interacting during the formation of proprioceptive sensory–motor reflex circuits) (Pecho-Vrieseling 2009) |
|
SH3BP1 mediates SEMA3E-induced cell collapse through interaction with PLXND1 and regulation RAC1 activity |
|
SEMA3E/PLXND1 modulates Immunological synapse (IS) formation and Ag-scanning activities of thymocytes within thymic tissues |
|
mesenchymal SEMA3D guides outgrowth of the common cardinal vein via repulsion and signals through PLXND1 |
|
SEMA3G induces cell collapse in an NRP2/PLXND1-dependent manner |
|
GIPC1-mediated endocytic trafficking regulates PLXND1 signaling, and PLXND1 binding to GIPC1 releases the autoinhibition, promoting its interaction with myosin VI |
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in metastatic melanomas (Roodink 2008) | tumoral
|  
|  
|  
| gain of function
|
in melanoma, breast, colon, ovarian and prostate cancers | constitutional
| germinal mutation
|  
|  
|  
|
in PLXND1 and REV3L that are responsible for a proportion of Möbius syndrome (MBS) patients suggesting that de novo mutations in other genes might account for other MBS patients | constitutional
| germinal mutation
|  
|  
|  
|
in isolated truncus arteriosus | |